WAVEMAN · COMPANY

HURN · Huron Consulting Group Inc.

LIVE

TEAM-2.62% 13F +440META+1.00% 13F +2,694RCG+0.35% CLUSTERUTHR-0.54% 13F +425CRWV+5.68% 13F +694CRM-1.97% 13F +1,019CVNA+1.58% 13F +795TPL-1.11% 13F +444NET-1.96% 13F +711MSTR-1.39% 13F +527DELL+1.50% 13F +1,204CRWD-0.87% 13F +1,383ANET+1.22% 13F +1,324COIN-4.18% 13F +475TEAM-2.62% 13F +440META+1.00% 13F +2,694RCG+0.35% CLUSTERUTHR-0.54% 13F +425CRWV+5.68% 13F +694CRM-1.97% 13F +1,019CVNA+1.58% 13F +795TPL-1.11% 13F +444NET-1.96% 13F +711MSTR-1.39% 13F +527DELL+1.50% 13F +1,204CRWD-0.87% 13F +1,383ANET+1.22% 13F +1,324COIN-4.18% 13F +475

← ALL COMPANIES

HURN

Name: Huron Consulting Group Inc. (HURN) insider trading and ownership data
Creator: WaveMan
License: https://wave-man.com/terms

Huron Consulting Group Inc.

PHARMA & BIOTECH · SERVICES-MANAGEMENT CONSULTING SERVICES · CIK 0001289848

FORM 144 · 4☆ WATCH

INSIDER NET · 180D

-$4.9M

open-market buys minus sells, Form 4 codes P and S

INSIDER BUYERS · 180D

CONGRESS BUYERS · 1Y

FUNDS ADDED · QTR

118

13F, latest reported quarter

REVENUE GROWTH

+11.9%

XBRL, annual

NET MARGIN

6.3%

SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST

INSIDERS

net -$4.9M over 180 days

-$4.4M over 90 days

below 77% of Pharma & Biotech

CONGRESS

no member of Congress has reported trading it

FUNDS

118 funds added or opened last quarter

more than 71% of Pharma & Biotech

REVENUE

+11.9% year over year

more than 62% of Pharma & Biotech

MARGIN

6.3% net margin

more than 75% of Pharma & Biotech

BUYBACKS

$153.1M repurchased, FY to 2026-03-31

more than 72% of Pharma & Biotech

SHORT

4.8% of shares outstanding short · 1.7 days to cover · settled 2026-07-31

more than 52% of Pharma & Biotech

THE SITUATION · EVERY LINE IS ONE RULE OVER ONE DATASET

Insiders are net sellers: -$4.9M across 7 people in 180 days.

118 funds added or opened positions in the latest 13F quarter, of 246 holders.

The year, with the filings on it

Total return indexed to 100 over the last 12 months · every marker is a federal filing, placed at its date — hover any marker for the detail

TOTAL 12M RETURN +12.7%

+12.7%12M

INSIDER SELLFORM 144

INDEXED RETURN, DIVIDEND-ADJUSTED — NOT A PRICE CHART · LARGE TRADES DRAWN FIRST WHEN A NAME FILES HEAVILY

Live price

Daily candles from TradingView, on their licence — no filings are marked on this one

WHY THIS NAME IS ON THE DESK

Insiders have filed to sell — before selling.

The record shows a net $4.9M sold by insiders over 180 days, 118 funds added last quarter, $4.4M in planned Form 144 sales. Every figure is a federal filing, dated the day it became public.

Backtest this pattern Open the screener

Same sector, ranked by filing activity

Sector from the SEC's own SIC classification

UTHR CPIX MRNA REGN LLY ALNY ELF CITR MDGL DNA VRTX NUVL

Insider transactions

Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

Over the last 180 days, Huron Consulting Group Inc. insiders sold a net $4.9M of stock across 252 Form 4 purchases and sales, with 0 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-06.

INSIDER

FILED

VALUE

Zumwalt Debra

Director

SELL

2026-08-14

82.0

$12.8K

SAWYER HUGH E III

Director

SELL

2026-08-11

2,000.0

$308.5K

Featherstone Kyle

Chief Acct Officer, Controller

SELL

2026-07-31

459.0

$70.1K

Hussey C. Mark

CEO and President

SELL

2026-07-29

4,972.0

$796.9K

Hussey C. Mark

CEO and President

SELL

2026-07-29

1,142.0

$184.3K

252 TRANSACTIONS ON RECORD

Showing the most recent few. Create a free account to see 247 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders

13F · holdings as of the latest quarter funds have reported

BlackRock, Inc.

1,388,544.0 sh

$125.2M

FIDUCIARY MANAGEMENT INC /WI/

1,293,304.0 sh

$116.6M

Boston Partners

802,604.0 sh

$73.2M

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

729,057.0 sh

$65.7M

VANGUARD PORTFOLIO MANAGEMENT LLC

708,737.0 sh

$63.9M

SCHEDULE 13D/G

No 5%+ ownership filings

Nobody has crossed 5% with a filing obligation. Absence is a fact here, not missing data.

Planned sales · Form 144

Filed before the sale — intent, not a trade

Zumwalt Debra

FILED 2026-08-14

$12.8K

SAWYER HUGH E III

FILED 2026-08-11

$308.5K

Featherstone Kyle

FILED 2026-07-31

$70.1K

Hussey C. Mark

FILED 2026-07-29

$4.0M

Fund concentration

N-PORT · funds ranked by how much of THEMSELVES they put in this stock — the conviction number 13F cannot show

FMI Common Stock Fund

$56.9M POSITION · AS OF 2026-03-31

3.2%

Rockefeller US Small Cap Core Fund

$2.8M POSITION · AS OF 2026-02-28

2.8%

Nationwide Renaissance Small Cap Growth Fund

$498.4K POSITION · AS OF 2026-04-30

2.1%

Aristotle Small Cap Equity Fund

$2.3M POSITION · AS OF 2026-03-31

2.0%

Putnam VT Small Cap Growth Fund

$706.3K POSITION · AS OF 2026-03-31

1.9%

Putnam Small Cap Growth Fund

$51.4M POSITION · AS OF 2026-03-31

1.9%

SEC N-PORT, MONTHLY WITH A ~60-DAY PUBLIC LAG · FUNDS ≥ $10M · % = SHARE OF THE FUND'S OWN BOOK

Government contracts

USASpending.gov · total award ceilings over the contract's life, including awards won through subsidiaries — not annual revenue

Nuclear Regulatory Commission

BUDGET FORMULATION SYSTEM (BFS) OPERATIONS, MAINTENANCE AND ENHANCEMENT CONTRACTOR SUPPORT · 2021-08-23

$5.3M

FEDERAL AWARDS ≥ $25M IN THE LAST 90 DAYS · MATCHED VIA SAM.GOV PARENT REGISTRY

Executive pay vs shareholder return · C. Mark Hussey

DEF 14A pay-versus-performance disclosure · both the headline pay and the SEC's mark-to-market figure, beside the return the company delivered and the return of the peer group it chose itself

CEO TOTAL

ACTUALLY PAID

OTHER NEOs AVG

TSR

PEER TSR

2025

$7.2M

$14.3M

$2.3M

+193%

+54%

2024

$6.5M

$10.5M

$2.2M

+111%

+76%

2023

$5.7M

$10.2M

$2.4M

+74%

+78%

2022

$6.1M

$8.8M

$2.6M

+23%

+48%

2021

$3.6M

$1.4M

$1.6M

-15%

+41%

TAGGED BY THE COMPANY UNDER SEC ITEM 402(v) · RETURN IS CUMULATIVE FROM THE START OF THE DISCLOSURE PERIOD · GREEN WHERE THE COMPANY BEAT ITS OWN PEER GROUP

Fundamentals

Annual figures from XBRL filings · pick a past date to see them exactly as the market knew them then — restatements and all

	2025-12	2024-12	2023-12	2022-12
REVENUE	$1.7B	$1.5B	$1.4B	$1.1B
OPERATING INCOME	$178.6M	$168.8M	$125.3M	$99.8M
NET INCOME	$105.0M	$116.6M	$62.5M	$75.6M
EPS (DILUTED)	5.84	6.27	3.19	3.64
OPERATING CASH FLOW	$193.4M	$201.3M	$135.3M	$85.4M
CASH	$24.5M	$21.9M	$12.1M	$11.8M
LONG-TERM DEBT	$489.7M	$342.9M	$324.0M	$290.0M
BUYBACKS	$166.7M	$123.0M	$122.8M	$120.4M

SEC XBRL · FISCAL-YEAR PERIODS · AS KNOWN ON 2026-09-06 · NOBODY ELSE SHOWS FUNDAMENTALS AS OF A PAST DATE